Take Your Trading To The Next Level. Get Started Here!
+1 (949) 514 8188
The RSV shot, called Arexvy, booked £1.2 billion, or $1.5 billion, in sales after only being on the market for roughly half a year.
GSK posts blowout RSV vaccine sales, raises outlook as shots give big pharma a boost
The RSV shot, called Arexvy, booked £1.2 billion, or $1.5 billion, in sales after only being on the market for roughly half a year.
Archives
Categories
Archives
Recent Posts
Meta
Categories
Calender